paclitaxel has been researched along with Cystadenoma, Serous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chay, D; Cho, H; Choi, SM; Kang, ES; Kim, BW; Kim, JH; Kim, YT; Lim, BJ; Oh, YJ | 1 |
| Oh, HC; Seo, DW; Song, TJ | 1 |
| Bondiau, PY; Foa, C; Frenay, M; Gérard, JP; Largillier, R; Rasendrarijao, D | 1 |
3 other study(ies) available for paclitaxel and Cystadenoma, Serous
| Article | Year |
|---|---|
ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Cell Culture Techniques; Cell Line, Tumor; Cystadenoma, Serous; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Protein Disulfide-Isomerases; Up-Regulation; Xenograft Model Antitumor Assays | 2010 |
Resolution of a septated pancreatic cyst by booster endoscopic ultrasonography-guided ablation.
Topics: Ablation Techniques; Adult; Antineoplastic Agents, Phytogenic; Cystadenoma, Serous; Endosonography; Female; Follow-Up Studies; Humans; Paclitaxel; Pancreatic Cyst; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
[Treatment of brain metastasis from ovarian cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; CA-125 Antigen; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cystadenoma, Serous; Female; France; Headache; Humans; Magnetic Resonance Imaging; Metrorrhagia; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Treatment Outcome | 2003 |